Scientific Advances in Thoracic Oncology 2016

Ross A. Soo, Emily C. A. Stone, K. Michael Cummings, James R. Jett, John K. Field, Harry J. M. Groen, James L. Mulshine, Yasushi Yatabe, Lukas Bubendorf, Sanja Dacic, Ramon Rami-Porta, Frank C. Detterbeck, Eric Lim, Hisao Asamura, Jessica Donington, Heather A. Wakelee, Yi-Long Wu, Kristin Higgins, Suresh Senan, Benjamin SolomonDong-Wan Kim, Melissa Johnson, James C. H. Yang, Lecia V. Sequist, Alice T. Shaw, Myung-Ju Ahn, Daniel B. Costa, Jyoti D. Patel, Leora Horn, Scott Gettinger, Solange Peters, Murry W. Wynes, Corinne Faivre-Finn, Charles M. Rudin, Anne Tsao, Paul Baas, Ronan J. Kelly, Natasha B. Leighl, Giorgio V. Scagliotti, David R. Gandara, Fred R. Hirsch*, David R. Spigel

*Bijbehorende auteur voor dit werk

Onderzoeksoutputpeer review

39 Citaten (Scopus)


Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

Originele taal-2English
Pagina's (van-tot)1183-1209
Aantal pagina's27
TijdschriftJournal of Thoracic Oncology
Nummer van het tijdschrift8
StatusPublished - aug.-2017

Citeer dit